Search by Drug Name or NDC

    NDC 60505-0257-01 Desmopressin Acetate 0.1 mg/1 Details

    Desmopressin Acetate 0.1 mg/1

    Desmopressin Acetate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is DESMOPRESSIN ACETATE.

    Product Information

    NDC 60505-0257
    Product ID 60505-0257_9ce2fc5c-13ed-1b31-c284-d21c1ddbc8ef
    Associated GPIs 30201010100310
    GCN Sequence Number 019596
    GCN Sequence Number Description desmopressin acetate TABLET 0.1 MG ORAL
    HIC3 P2B
    HIC3 Description ANTIDIURETIC AND VASOPRESSOR HORMONES
    GCN 26171
    HICL Sequence Number 002841
    HICL Sequence Number Description DESMOPRESSIN ACETATE
    Brand/Generic Generic
    Proprietary Name Desmopressin Acetate
    Proprietary Name Suffix n/a
    Non-Proprietary Name desmopressin acetate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.1
    Active Ingredient Units mg/1
    Substance Name DESMOPRESSIN ACETATE
    Labeler Name Apotex Corp.
    Pharmaceutical Class Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077414
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-0257-01 (60505025701)

    NDC Package Code 60505-0257-1
    Billing NDC 60505025701
    Package 100 TABLET in 1 BOTTLE (60505-0257-1)
    Marketing Start Date 2006-03-07
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.38462
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DESMOPRESSIN ACETATE 0.1 MG TB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis